Clinical trial · Observational
Molecular Determinants of Persistent Cancer Related Fatigue
NCT01980719CI-TRIAL-00017280MDOFcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if inflammatory markers in blood as well as brain neurotransmitters (markers of in-brain activity and metabolism) are related to long-term or chronic fatigue.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fatigue | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Poor Sleep Quality | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Healthy, Age-Matched
- label
- Fatigued
- label
- Not Fatigued
Primary outcomes (1)
- measure
- Compare peripheral immune markers (cytokines), C-reactive protein levels and brain neurotransmitters (glutamate, GABA, myoinositol, and resting state intrinsic connectivity).
- timeFrame
- 6 weeks
Secondary outcomes (1)
- measure
- Compare fatigue, pain, and sleep quality with peripheral immune markers, CRP, and brain markers.
- timeFrame
- 6 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: All Participants: \- Women age 18 or older with no contraindication to magnetic resonance imaging(MRI); Fatigued BC Participants: * Have a diagnosis of breast cancer; * And have completed all cancer-related treatments (i.e., surgery, chemotherapy, radiotherapy, immunotherapy, etc.) except for hormonal therapy and or herceptin at least 12 weeks previously; and be apparently cancer-free. Age-Matched, Healthy Participants: * Generally healthy; * Matched in age ± 2.5 years to a Fatigued BC participant. * No prior history of any cancer except for basal cell or squamous cell tumors of the skin that have been surgically excised; * Have good sleep quality * Have no chronic pain * Have no chronic fatigue Exclusion Criteria: * Pregnant, wanting to become pregnant or lactating women ; * Diagnosed with anemia \[defined as hemoglobin levels \< 12 gm/dl\] or receiving treatment for anemia ; * Diagnosed with any comorbidities likely to cause significant fatigue (i.e., moderate to severe heart failure) * Diagnosed with nutritional deficiencies; * Have a diagnosis of untreated hypo- or hyper-thyroidism * Have an initiation, a cessation or change of dose (up to three weeks prior to the study's start) of any chronic medications or dietary supplements or any planned change of chronic medications or dietary supplements during the study; * Have implanted (e.g., surgical clips or staples) metal objects.
References
Publications (0)
Data not yet available
No reference posted for this study.